When the Body Turns Inward: What Extended Fasting Really Does

The human body is built for more than one metabolic season.

It knows how to receive food, store energy, build tissue and respond to abundance. It also knows how to move through periods when food is absent. During a prolonged fast, the body does not simply continue normal life with an empty stomach. It changes fuel, reorganizes priorities and alters signals involved in growth, maintenance, inflammation and repair.

That biological reach is why extended fasting deserves better than either dismissal or mythology.

Human studies show substantial changes in fuel use, blood pressure, body composition, circulating proteins and immune activity. Some findings are clinically meaningful. Others are biomarkers that may eventually lead somewhere important. The most dramatic claims about autophagy, stem cells and cancer still run ahead of what has been demonstrated in humans.

This article follows the evidence as far as it goes, and stops where it stops.

The short version: prolonged fasting is an active, coordinated metabolic state. Its strongest clinical evidence currently sits in selected cardiometabolic settings, especially elevated blood pressure under medical supervision. Its wider therapeutic potential is serious enough to study, but not settled enough to turn into a universal treatment or a home protocol.

Evidence guide

A timeline without a magic clock

These are overlapping physiological ranges, not instructions or promises. Individual timing changes with context.

First 12-24 hours
Stored fuel carries the transition
Liver glycogen helps maintain blood glucose while insulin falls and fat release increases. The timing varies with prior diet, activity and metabolic health.
Roughly 24-72 hours
Fat and ketones take a larger role
Gluconeogenesis continues while ketone production rises. This is a progressive shift, not a single switch thrown at one exact hour.
After about two to three days
The response becomes more system-wide
A seven-day human proteomics study found broad protein changes becoming clearly detectable after three days. It did not establish a universal therapeutic threshold.
Additional fasting days
Adaptation deepens and costs accumulate
Ketosis, lower growth signalling and continued fat use coexist with fluid shifts, protein loss, reduced high-intensity endurance and rising supervision needs.
Refeeding
Suppression gives way to rebuilding
Insulin and growth signals return, glycogen and water are restored, and rebuilding can begin. Refeeding is part of the intervention, not an afterthought.

How claims are labelled

Well establishedCore fuel shifts and basic fasting physiology are supported by decades of human metabolic research.
Promising clinical evidenceHuman studies show meaningful signals, but study size, design or bundled refeeding limits certainty.
Mostly preclinical evidenceThe mechanism is plausible or strong in animals and cells, but a human clinical benefit has not been established.

The Ancient Capacity Modern Life Rarely Uses

Human history has never provided food at perfectly regular intervals. Season, migration, weather, harvest, illness, conflict and simple scarcity all created periods of reduced intake. The capacity to move between fed and fasted states is therefore not an internet invention. It is part of ordinary human physiology.

That does not romanticize famine or chronic undernutrition. Involuntary starvation is shaped by fear, deprivation, disease, poor sanitation and lack of control. A medically supervised therapeutic fast is a different context with screening, monitoring, a defined end point and structured refeeding.

The shared biology is that the body can maintain life when dietary energy stops arriving. The meaningful question is what happens inside that adaptation, what benefits it may produce, what it costs, and when those costs become unacceptable.

Modern life often keeps us in the fed state for most waking hours. That does not make eating a problem. It does mean that deeper fasting physiology is rarely reached by accident. Skipping breakfast, eating within a daily window and completing several days without energy intake are not interchangeable interventions.

Fasting Is an Active Biological State

The word fasting covers very different practices.

An overnight fast may last 10 to 14 hours. Time-restricted eating changes the daily window in which food is consumed. Alternate-day and intermittent fasting repeatedly cycle shorter periods of restriction. A 24- or 48-hour fast reaches further into stored fuel. A three- to seven-day water-only fast creates a deeper and more sustained shift. Published clinic studies sometimes include fasts lasting one to several weeks under residential medical supervision.

A fasting-mimicking diet, or FMD, is different again. It supplies a small, specifically designed amount of food while attempting to reproduce selected metabolic features of fasting. Findings from an FMD cannot be presented as findings from water-only fasting.

Prolonged fasting is also not the same as continuous calorie restriction. With calorie restriction, energy keeps arriving, though in smaller amounts. In a complete fast, the absence of dietary carbohydrate, fat and protein changes the hormonal environment and forces a more decisive transition toward stored fuel.

In this article, extended or prolonged fasting generally means more than 24 hours, with special attention to three- to seven-day fasting and to longer fasts only where supervised clinical research has examined them.

The Metabolic Switch

After the last meal, the body first works with fuel already in circulation and glycogen stored mainly in the liver and muscles. Liver glycogen helps maintain blood glucose between meals. As that supply falls, insulin declines and glucagon becomes relatively more influential.

Lower insulin removes part of the restraint on lipolysis, the release of fatty acids from adipose tissue. The liver converts an increasing share of those fatty acids into ketone bodies. Meanwhile, gluconeogenesis continues making the glucose still required by cells and tissues that cannot fully substitute ketones.

This transition is sometimes called the metabolic switch. The phrase is useful as long as it does not imply an on-off moment.

Glycogen depletion and ketone production vary with body size, recent carbohydrate intake, activity, liver glycogen, insulin sensitivity and the demands placed on the body. Ketones can rise within the first day, but deeper nutritional ketosis develops progressively. The brain gradually uses more ketones, reducing but not eliminating its glucose requirement.

Protein contributes to glucose production, especially earlier in fasting. As ketones rise, the body becomes better able to spare some protein, but protein loss does not become zero. Fasting is economical, not cost-free.

Well established: declining insulin, increased fat mobilization, ketone production and continued gluconeogenesis are central features of human fasting physiology.

Why the Third Day Is Different - Without a Magic Timer

A small but unusually detailed human study followed 12 healthy volunteers through seven days of water-only fasting and measured nearly 3,000 circulating proteins each day. Participants lost an average of 5.7 kilograms, and more than 1,000 proteins changed during the study. Broad, system-wide protein changes became clearly detectable after about three days. The authors linked some of those proteins to pathways involving the extracellular matrix, immunity and organ-specific biology. (Pietzner et al., Nature Metabolism, 2024)

That finding matters. It suggests that multi-day fasting is not merely a longer version of missing breakfast. After the early fuel transition, the circulating protein landscape becomes more extensively reorganized.

It does not prove that hour 72 is a universal healing threshold.

The study was small, had no control group and measured proteins rather than disease outcomes. The three-day pattern describes what became statistically visible in this group with this sampling design. A person beginning with low glycogen after a low-carbohydrate diet may move through parts of the transition differently from someone beginning after several high-carbohydrate meals. Activity, sex, body composition and metabolic health may shift the timing too.

The useful conclusion is not "three days activates repair." It is that the biology appears to deepen and broaden after the first two to three days, and that the exact timing is contextual.

Growth Signals, Ketones and Cellular Maintenance

Feeding tells the body that raw materials are available. Amino acids, glucose and insulin support protein synthesis, tissue growth and storage. Fasting changes that message.

Insulin falls. Insulin-like growth factor 1, or IGF-1, may fall during longer fasting. Activity in the mTOR pathway, which responds to amino acids and energy availability, can decrease. Energy-sensing pathways including AMPK become more relevant. Human skeletal-muscle research has found increased release of the amino acid phenylalanine and reduced mTOR signalling during a 72-hour fast, evidence that growth and protein synthesis are being downregulated while some protein is being broken down. (Vendelbo et al., PLOS ONE, 2014)

This is often described as a shift from growth toward maintenance. That is directionally useful, but maintenance during fasting includes trade-offs. Lower growth signalling may support stress resistance and cellular housekeeping. It also means the body has fewer dietary building blocks and is not prioritizing new tissue synthesis.

Ketones are part of this change. Beta-hydroxybutyrate is not only a fuel. It can act as a signalling molecule and influence gene expression, oxidative stress and inflammatory pathways. Much of the mechanistic detail comes from animal or cell research, while human studies clearly establish ketone production and can measure associated biomarkers.

Supported but variable: prolonged fasting reliably changes insulin, ketones and growth-related signals in humans. Translating those changes into a precise dose of repair or a guaranteed clinical benefit is not yet possible.

Autophagy Without the Internet Clock

Autophagy is the cellular process of enclosing and breaking down damaged, unnecessary or recyclable material. The resulting components can be reused. It is essential housekeeping, not an emergency programme that remains completely off while food is present.

Basal autophagy is always occurring. Nutrient deprivation can increase autophagic activity in laboratory models, and the pathways changed by fasting, including insulin, mTOR and AMPK signalling, make the connection biologically plausible.

The human measurement problem is substantial.

Autophagy is dynamic. Measuring the number of autophagosomes at one moment cannot always reveal whether more material is being created, moved or successfully degraded. Blood cells do not necessarily represent liver, muscle, brain or intestinal tissue. Repeated biopsies across several days of fasting are difficult, and circulating markers are indirect.

Recent human work has begun measuring autophagic flux in peripheral blood cells during time-restricted eating and markers during fasting-mimicking diets. That is progress, but it does not supply a whole-body clock for water-only fasting.

There is no responsible scientific basis for saying that autophagy starts at 18, 24, 48 or 72 hours in every person. A more accurate statement is that fasting changes nutrient-sensing pathways in a direction expected to increase cellular recycling in at least some tissues, while the magnitude, timing and clinical meaning in living humans remain incompletely mapped.

Mostly preclinical evidence: fasting-induced autophagy is strong biology. A universal human timetable and direct proof that a given fasting duration produces a specific therapeutic outcome are not established.

The Stem-Cell Claim: Real Biology, Premature Certainty

One of the most repeated fasting claims says that a 72-hour fast "regenerates the immune system" or "creates new stem cells." It is based loosely on important research, but the popular version removes the study design.

In 2014, Cheng and colleagues reported that repeated cycles of prolonged fasting reduced IGF-1 and protein kinase A signalling in mice, increased stress resistance and promoted hematopoietic stem-cell regeneration during refeeding. The model involved cycles of fasting and recovery, not one isolated clock crossing. (Cheng et al., Cell Stem Cell, 2014)

The human portion was small and involved people receiving chemotherapy who fasted for different periods. It provided preliminary information about white blood cells and treatment context. It did not demonstrate that a healthy human begins producing stem cells at 72 hours, nor that one three-day fast resets immunity.

The underlying concept remains compelling: nutrient scarcity suppresses growth signals, and refeeding may create conditions for renewed proliferation. In mice, that sequence can affect hematopoietic regeneration. Whether the same effect occurs to a clinically meaningful degree in healthy humans, in which tissues, at which duration and with what repeated pattern is not yet known.

The science is more interesting when we keep the uncertainty. Regeneration may depend as much on refeeding as on fasting.

The Strongest Clinical Evidence: Blood Pressure and Metabolic Health

The clearest clinical signal for longer water-only fasting is blood pressure reduction in selected people with hypertension.

A 2001 observational cohort included 174 people with blood pressure above 140/90 mmHg. Participants completed a short prefast diet, an average water-only fast of roughly 10 to 11 days, and supervised refeeding with a low-fat, low-sodium vegan diet. Nearly 90 percent reached blood pressure below 140/90. The average reduction was 37 mmHg systolic and 13 mmHg diastolic. All 24 people taking antihypertensive medication at entry discontinued it under medical supervision. (Goldhamer et al., Journal of Manipulative and Physiological Therapeutics, 2001)

Those numbers are large. The design still cannot separate the water-only fast from sodium reduction, residential care, refeeding, later diet or regression to the mean. There was no randomized usual-care control.

A newer prospective single-arm study followed 29 adults with stage 1 or stage 2 hypertension and no type 2 diabetes. The median fast lasted 11 days, with a range from 7 to 40 days, followed by about five days of structured whole-plant-food refeeding. Median blood pressure was 135/81 at baseline, 125/84 at the end of the fast and 114/78 at the end of refeeding. Body weight fell by more than 5 percent, and antihypertensive medication was withdrawn under supervision. Reported benefits persisted at six weeks and, for the smaller group with longer data, potentially to one year. Most adverse events were mild and no serious adverse event occurred in this selected cohort. (Zeiler et al., Nutrients, 2024)

Again, there was no control group. Participants were screened, medication had to be safely discontinued, vitals were checked twice daily, laboratory testing was repeated and the intervention took place in a residential centre.

A related follow-up study enrolled 40 adults with overweight or obesity; 33 completed the full protocol. After a median 14-day fast, six-day refeed and 45-day follow-up, body weight, waist circumference, blood pressure, total cholesterol, LDL cholesterol, high-sensitivity CRP and fatty-liver index remained below baseline. Triglycerides and insulin-resistance estimates rose by the end of refeeding and returned toward baseline at follow-up. (Gabriel et al., Nutrients, 2022)

Promising clinical evidence: the blood-pressure signal is consistent and potentially important. Controlled trials are still needed to determine how much comes from fasting itself, how much comes from refeeding and dietary change, and which patients benefit more than they would from less intensive care.

Fasting and Immune Regulation

Fasting changes immune biology, but its effects cannot be described simply as anti-inflammatory.

A five-day water-only fasting trial in 46 adults of normal weight reported lower glucose, insulin, IGF-1 and several metabolic-risk markers, alongside changes in immune-cell proportions and markers associated with regulatory T cells. The study had no non-fasting control and focused on biomarkers rather than illness. (Jiang et al., Clinical and Translational Medicine, 2021)

Leukocyte counts can fall during longer fasting and return during refeeding. In some contexts, lower inflammatory markers after a fasting-plus-refeeding intervention look favourable. In other contexts, the acute fast appears inflammatory.

A 2025 study of 20 volunteers undergoing about ten days of medically supervised water-only fasting followed by refeeding measured 1,317 plasma proteins. It found a coordinated rise in acute inflammatory signals including C-reactive protein, hepcidin, midkine and interleukin 8. Platelet degranulation, complement and coagulation pathways also changed, and a urinary marker of platelet activation rose. Some lipid markers worsened temporarily during fasting; many changes moved back toward baseline with refeeding. (Commissati et al., Molecular Metabolism, 2025)

This does not automatically mean prolonged fasting is harmful. Acute inflammation can be part of adaptation, tissue turnover or stress. It also cannot be brushed aside as proof that the body is "detoxing." The study was small and uncontrolled, but it challenges the claim that fasting uniformly suppresses inflammation.

The honest synthesis is that fasting redistributes immune activity. Direction depends on the marker, timing, tissue, population and whether measurement occurs during fasting or after refeeding.

The Frontier: Autoimmunity, Cancer and Therapeutic Fasting

Rheumatoid arthritis provides one of the older clinical examples. A 1991 randomized trial assigned 27 participants to an initial 7- to 10-day subtotal fast followed by a gluten-free vegan and later lactovegetarian diet, while 26 controls ate an ordinary diet. Joint counts, pain, morning stiffness and inflammatory markers improved in the intervention group, with group differences persisting at one year. Because fasting was followed by a sustained dietary programme, the result cannot be attributed to fasting alone. (Kjeldsen-Kragh et al., The Lancet, 1991)

A modern exploratory trial compared a seven-day fast followed by 11 weeks of plant-based eating with a guideline-based anti-inflammatory diet in 53 people with rheumatoid arthritis. The primary disability outcome did not differ significantly between groups at 12 weeks. Both groups improved in disease activity; the fasting group improved more rapidly at day seven and lost more weight. (Hartmann et al., Frontiers in Nutrition, 2022)

That is promising for a combined dietary strategy, not proof that water-only fasting treats autoimmune disease.

Cancer research requires even tighter language. Preclinical studies suggest that fasting conditions may make healthy and malignant cells respond differently to stress. Human oncology trials have mainly studied fasting-mimicking diets as an adjunct to standard care.

In the phase 2 DIRECT trial, 131 people with HER2-negative stage II or III breast cancer were assigned to an FMD or regular diet around neoadjuvant chemotherapy. Toxicity did not differ overall. Radiological response favoured the FMD group, and favourable pathological response appeared in per-protocol analysis, but adherence was difficult and the findings were not a demonstration that fasting treats cancer independently. (de Groot et al., Nature Communications, 2020)

A 2024 case series described three people with low-grade follicular lymphoma whose lymph-node size and metabolic activity decreased during periods that included prolonged water-only fasting and an exclusively whole-plant-food diet. The changes were reviewed by their oncologists, but three uncontrolled cases cannot establish efficacy, exclude the natural course of indolent lymphoma or separate fasting from diet and other care. The centre's owner was an author. (Gabriel et al., Journal of Medical Case Reports, 2024)

Cancer treatment should never be delayed, replaced or modified for fasting without the oncology team. Weight loss and malnutrition can directly worsen tolerance and outcomes. The frontier is adjunctive research in carefully selected patients, not independent treatment.

Clinical Case Study: What TrueNorth Actually Teaches Us

TrueNorth Health Center was founded in California in 1984 and built a residential model around medically supervised water-only fasting followed by structured whole-plant-food refeeding. Its current website states that founder Alan Goldhamer has supervised fasting for more than 25,000 patients over four decades. That is the centre's own operational claim, not an independently audited measure of efficacy. (TrueNorth Health Center)

What Supervision Means in the Published Protocol

In the research papers, "supervised" is not a decorative word.

Potential participants complete medical history and physical assessment. Published studies describe baseline blood and urine testing, review of diagnoses, screening for contraindications and medication management before fasting. People whose medication cannot be safely withdrawn are not accepted into some protocols.

During residential fasting, participants rest, drink water and receive physician review. The newer hypertension study recorded vital signs twice daily, weekly laboratory tests and adverse events. Clinical findings can shorten or end the fast. Refeeding is staged and commonly lasts at least half the fasting duration, beginning with foods selected by the centre and progressing toward minimally processed plant foods.

This is not a home template. It shows why research on a 7- to 40-day fast cannot be translated into "do the same thing with a water bottle."

What the Research Platform Has Produced

The 2001 hypertension cohort and 2024 prospective hypertension study produced the centre's strongest clinical signals. The 2022 six-week follow-up and 2025 body-composition analysis added information about what persisted after refeeding.

The 2018 safety review examined 768 visits involving at least two days of water-only fasting. Across all recorded adverse events, 75 percent were mild. In 555 visits, the highest event grade was 2 or lower; in 212 visits it was grade 3; one visit included a grade 4 event; none included a grade 5 event or death. Two visits required hospitalization. The paper prints an incorrect percentage beside that number: 2 divided by 768 is approximately 0.26 percent, not 0.002 percent. One hospitalization involved dehydration and the other hyponatremia. (Finnell et al., BMC Complementary and Alternative Medicine, 2018)

That review is reassuring in one sense and sobering in another. Serious events were uncommon in a specialist centre, while symptoms and clinically graded events were not rare. It cannot estimate safety for unsupervised fasting or for people excluded by screening.

The 2025 body-composition analysis and inflammation study used participants from the same research environment. They show the value of repeated measurements across fasting and refeeding, including findings that complicate a promotional story: acute lean-mass and fluid changes, inflammatory signalling, platelet activation and temporary lipid changes.

Why the Evidence Matters

Few clinical settings have comparable experience observing multi-day and multi-week water-only fasting. Residential care makes timing, adverse events, medication changes and refeeding easier to document. Prospective sample collection can test hypotheses generated by decades of clinical observation. The blood-pressure reductions are large enough to justify randomized comparison.

Why It Does Not Settle the Question

Many studies are small, single-arm, retrospective or secondary analyses. Participants self-select into an intensive residential programme. The fast is bundled with rest, medical attention, whole-plant-food refeeding and later dietary change. Blinding is not practical, but control groups remain possible. Long-term follow-up is limited.

Several authors work for or have financial relationships with the centre and its foundation. That does not invalidate the data. It increases the importance of independent replication and transparent trial design.

TrueNorth does not prove every therapeutic claim made for fasting. It does show that prolonged water-only fasting can be studied and delivered as a structured medical intervention, including fasts far longer than those normally discussed online. Its strongest published outcomes justify larger randomized trials, especially in hypertension and cardiometabolic disease.

What the Body Gives Up - and What It Regains

Rapid weight loss during fasting is visually persuasive but biologically mixed.

Early loss includes glycogen, the water stored with it, sodium, intestinal contents and body water. Fat use rises and fat mass falls. Protein breakdown contributes too. A scale cannot separate these compartments.

DXA scanning divides the body into fat mass, bone mineral content and fat-free mass. Fat-free mass is not identical to skeletal muscle. It includes water, organs, connective tissue and other lean components, and hydration shifts can substantially change the reading.

A 2025 secondary analysis followed 29 adults through a median 14-day fast, six-day refeed and six-week follow-up. At the end of fasting, fat-free mass accounted for a large share of the measured weight loss. During refeeding, about 2.5 kilograms of fat-free mass returned. At six weeks, fat mass and visceral fat remained below baseline, and fat made up roughly two-thirds of the remaining weight loss. The study was small, uncontrolled and mostly included postmenopausal women. (Gabriel et al., Obesity Science and Practice, 2025)

A 2026 meta-analysis of 49 prolonged-fasting studies reached a broader conclusion: body weight, BMI, waist circumference and fat mass generally decrease, but so do fat-free mass and total body water. Duration did not show a simple linear relationship with most body-composition outcomes. (Ulupinar et al., Nutrition Reviews, 2026)

The slogan "fasting burns muscle" is too crude. So is "fasting preserves all muscle." Some apparent lean loss is fluid and glycogen and can return quickly. Protein loss and some tissue loss can still occur, especially as fasting lengthens.

Physical function adds another layer. In a 2025 study, 13 active adults completed seven days of water-only fasting. Maximal leg strength and muscle oxidative enzymes were preserved, while high-intensity endurance and carbohydrate oxidation declined. The sample was small and healthy; performance preservation in these participants does not guarantee safety for frail or ill people. (Kolnes et al., Nature Communications, 2025)

Uric acid can rise because ketones compete with urate for renal clearance. Blood pressure and glucose may fall enough to make existing medication doses unsafe. Electrolyte and fluid changes can matter. These are not minor details around an otherwise pure metabolic experiment. They are part of the physiology.

Refeeding as the Second Half of Repair

Fasting reduces incoming energy and building material. Refeeding changes the direction again.

Insulin rises. Glucose enters cells. Glycogen and its associated water are restored. Amino acids support protein synthesis. Growth-related pathways reactivate. In animal models of intestinal and hematopoietic regeneration, the return of nutrients appears central to proliferation and rebuilding.

This is why "the fast did it" can be misleading. Some adaptations happen during deprivation; some rebuilding happens when deprivation ends. Clinical studies that combine fasting with structured plant-food refeeding are studying a sequence.

Refeeding can also be dangerous for people at increased risk of refeeding syndrome.

After substantial undernutrition, a carbohydrate-driven rise in insulin moves phosphate, potassium and magnesium into cells. Blood levels can fall. Fluid and sodium handling change. Thiamine demand rises as carbohydrate metabolism accelerates. Severe imbalance can affect the heart, lungs, nervous system and other organs.

NICE guidance treats more than five days with little or no nutritional intake as a reason to introduce nutrition carefully and assess risk. That does not mean every healthy person completing a five-day fast will develop refeeding syndrome. Risk rises with low body weight, recent major weight loss, existing electrolyte depletion, longer deprivation, alcohol use, disease, medication and baseline malnutrition. (NICE CG32, Nutrition support for adults)

Refeeding is not a reward meal and not administrative cleanup after the "real" intervention. It is a physiologically active phase that changes both benefit and risk.

Who Should Not Undertake Prolonged Fasting

Multi-day fasting is meaningfully different from skipping a meal. Anyone considering it in the presence of illness or medication needs qualified medical evaluation rather than a generic online rule.

Prolonged fasting may be unsuitable, unsafe or require specialist coordination in people who are:

pregnant or breastfeeding
children or adolescents
underweight, malnourished, frail or experiencing major unintentional weight loss
living with a current or previous eating disorder
living with type 1 diabetes or using insulin or other glucose-lowering medication
living with kidney, liver, cardiac or other serious disease
prone to gout, hyperuricemia or related complications
taking medication affected by food, hydration, electrolytes, blood pressure, glucose or kidney clearance
receiving active cancer treatment without explicit coordination from the oncology team

Baseline laboratory testing, electrolyte monitoring and medication adjustment may be necessary even when a person feels well. A medication dose designed for the fed state can become inappropriate when blood pressure, glucose, fluid balance or renal handling changes.

Persistent vomiting, fainting, confusion, chest pain, severe weakness, arrhythmia, inability to maintain hydration or other significant symptoms are not signs to push through for a deeper biological state.

This article is not a fasting prescription. It provides the scientific map needed to understand why duration, selection, supervision and refeeding matter.

An Underused Tool, Not a Universal Cure

Prolonged fasting is not merely the absence of food. It is a coordinated state that changes fuel use, insulin, ketones, growth signalling, circulating proteins, body composition and immune activity.

The strongest human clinical evidence points toward meaningful blood-pressure reduction and cardiometabolic change in carefully selected, medically supervised participants. The physiology behind autophagy and regeneration is real, but the popular clocks are not. Stem-cell renewal is compelling preclinical biology, not a universal 72-hour human result. Immune responses can include both potentially favourable regulation and acute inflammatory or platelet signals. Cancer and autoimmune research is promising at the frontier, especially as an adjunct, but not established as stand-alone treatment.

Fasting asks the body to live from itself for a time. That can reveal capacities ordinary feeding rarely calls upon. It also spends water, glycogen, fat and protein, changes medication needs and places increasing importance on refeeding.

An underused tool deserves serious trials, not exaggerated certainty.

The next questions are practical and clinical: Who benefits? Which condition? What duration? What form of refeeding? What monitoring? Compared with what alternative? And does the benefit remain after ordinary life returns?

That is where prolonged fasting belongs now: beyond dismissal, beyond mythology, and inside careful human research.